[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $llys

LLYs sees a massive XXX% surge in engagements, driven by discussions around weight loss drugs and BTK inhibitor competition. Top posts highlight LLYs' GLP-1 dominance and its role in the competitive obesity drug market.

### About $llys
LLYs is a cryptocurrency project focused on advancements in the pharmaceutical and biotechnology sectors.  

### Insights
- $llys engagements is up XXXXXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$llys/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$llys/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXXX +366%  
X Month: XXXXXX -XXXX%  
X Months: XXXXXXX +3%  
X Year: XXXXXXXXX -XXXX%  
1-Year High: XXXXXXX on 2025-04-01  
1-Year Low: X on 2025-06-05  

Engagements by network (24h):
X: XXX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$llys/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$llys/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: X  
X Week: XX +7.70%  
X Month: XX -XX%  
X Months: XXX +57%  
X Year: XXX +11%  
1-Year High: XX on 2025-08-08  
1-Year Low: X on 2025-01-12  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$llys/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$llys/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $llys in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X  
X Week: XX -XXXX%  
X Month: XX -XX%  
X Months: XXX +45%  
X Year: XXX +39%  
1-Year High: XX on 2025-08-08  
1-Year Low: X on 2025-01-12  

The most influential creators that mention $llys in the last XX hours

| Creator                                  | Rank | Followers | Posts | Engagements |
| -------                                  | ---- | --------- | ----- | ----------- |
| [@BiotechCH](/creator/twitter/BiotechCH) | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$llys/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$llys/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$llys/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% no change  
1-Year High: XXX% on 2025-01-01  
1-Year Low: XX% on 2025-07-01  

Most Supportive Themes:
- Pharmaceutical and Biotechnology Advancements: (75%) LLYs is a cryptocurrency project focused on advancements in the pharmaceutical and biotechnology sectors.
- Weight Loss Drug Market Competition: (25%) LLYs is a cryptocurrency project focused on advancements in the pharmaceutical and biotechnology sectors.
  
Most Critical Themes:
- BTK Inhibitor Space Competition: (50%) LLYs is a cryptocurrency project focused on advancements in the pharmaceutical and biotechnology sectors.
- Biotech Industry Trends and Deals: (50%) LLYs is a cryptocurrency project focused on advancements in the pharmaceutical and biotechnology sectors.
  

### Top $llys Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Biotech's on fire. $XBI up XX% YTD $XLV ripping on $LLY's GLP-1 dominance. $MRNA $PFE rebounding hard post-vax era. SEA healthcare spend exploding to $500B by 2030. But where's the asymmetric alpha Not in the giants. It's in the disruptors flying under radar. Enter $BNCM"  
[X Link](https://x.com/RoadtolamboOtc/status/2000629520022540489) [@RoadtolamboOtc](/creator/x/RoadtolamboOtc) 2025-12-15T18:10Z XXX followers, XXX engagements


"Cross trial comparison of next gen obesity drugs (table from JPM). $LLY's GGG (GLP1+GIP+ glucagon)vs $NVO's GA (GLP1+amylin). Both lead to XX% weight loss GGG looks more effective but GA is better tolerated so perhaps just a matter of dose intensity. When comparing these results to existing obesity drugs it seems like the appetite hormone class has potentially reached its ceiling"  
[X Link](https://x.com/ohadhammer/status/2000497056432128470) [@ohadhammer](/creator/x/ohadhammer) 2025-12-15T09:24Z 8038 followers, 21K engagements


"Time to sell some weekly $LLY Puts $LLY's best weeks of the year. XX years of data: 🟢Average gain of +2.3% 🟢68% win rate After LLYs monstrous run from AUG lows we seen a XX% gain We then hit the golden fib and pulled back We then bounced on previous ATH BULLISH 🔥"  
[X Link](https://x.com/JTE_Theta/status/2000346133600800944) [@JTE_Theta](/creator/x/JTE_Theta) 2025-12-14T23:24Z XXX followers, 1743 engagements


"At #ASH25 $LLYs Jaypicra announced Ph3 data highlighting fierce competition in the BTK inhibitor space with $ONC & others. The data from $LLY is very early. In general it's supposed to be safer but the safety differences honestly ended up being a little marginal says @YaronWerber. Finally $ONC has a monster pipeline in CLL including a BCL2 inhibitor in combination and a BTK degrader. Frankly they've moved their BTK degrader now to be tested head-to-head against $LLYs drug. So this is going to be fireworks for a while. Bottom line is you could argue: $ONC is no longer the absolute leader."  
[X Link](https://x.com/BiotechCH/status/1999537347122036952) [@BiotechCH](/creator/x/BiotechCH) 2025-12-12T17:50Z 15.5K followers, XXX engagements